Amyloidosis AA

Active Research Protocols

  1. 12-HG-0053 – International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of KIACTA in Preventing Renal Function Decline in Patients With AA Amyloidosis
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014